The opioid-exposed newborn: assessment and pharmacologic management.
The opioid-exposed newborn: assessment and pharmacologic management.
复制标题
DOI：
10.5055/jom.2009.0006
复制
发表时间：
2018-01
影响因子：
--
通讯作者：
L. Jansson;Martha L. Velez;C. Harrow
中科院分区：
文献类型：
--
作者：
L. Jansson;Martha L. Velez;C. Harrow
在宫内接触阿片类药物的婴儿经常对新生儿护理提供者在出生后评估和治疗新生儿禁欲综合征(NAS)的症状提出挑战。这篇综述的目的是为保健专业人员提供一个简短的审查，目前的证据和实践指南，以最佳的评估和药理学管理的阿片类药物暴露的新生儿。
The infant exposed to opioids in utero frequently presents a challenge to the neonatal care provider in the assessment and treatment of symptoms of Neonatal Abstinence Syndrome (NAS) after birth. This review is intended to provide the healthcare professional with a brief review of current evidence and practical guidelines for optimal evaluation and pharmacologic management of the opioid-exposed newborn.